| Type 2 Diabetes Mellitus |
1 |
1 |
| Biliary Disease |
0 |
0.9 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.91 |
| Liver Disease |
0 |
0.73 |
| Metabolic Syndrome |
0 |
0.73 |
| Liver |
0 |
0.72 |
| Fatty Liver |
0 |
0.7 |
| Aminotransferase |
0 |
0.65 |
| Alcoholism |
0 |
0.62 |
| Alcoholic Hepatic Steatosis |
0 |
0.6 |
| Hepatic Fibrosis |
0 |
0.53 |
| Addiction |
0 |
0.48 |
| Liver Transplantation |
0 |
0.46 |
| Hepatocellular Carcinoma |
0 |
0.38 |
| Preventive Screening |
0 |
0.99 |
| Prediabetes |
0 |
0.24 |
| Cardiometabolic Risk Factors |
0 |
0.23 |
| Cardiovascular Risk Management |
0 |
0.21 |
| Obesity |
0 |
0.21 |
| Cardiovascular disease |
0 |
0.16 |
| Cirrhosis |
0 |
0.16 |
| Electronic Medical Record |
0 |
0.16 |
| Electronic Health Record (EHR) |
0 |
0.14 |
| Type 1 Diabetes Mellitus |
0 |
0.1 |
| Endocrinology |
0 |
0.08 |
| Statins |
0 |
0.08 |
| Platelet Count |
0 |
0.07 |
| Lipids Management |
0 |
0.06 |